| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price |
|---|---|---|---|---|---|---|---|---|
| CD74 | Human CD74 / DHLAG Protein, His Tag, low endotoxin (HPLC verified) | Human | HEK293 | ![]() | HPLCSDS-PAGE | $325.00 100ug | ||
| CD74 | Human CD74 / DHLAG Protein, Fc Tag (MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $415.00 100ug | ||
| CD74 | Human CD74 / DHLAG Protein, Llama IgG2b Fc Tag, low endotoxin | Human | HEK293 | ![]() | SDS-PAGE | $390.00 100ug |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Influenza A M1 vaccine (Pascal Biosciences) | Phase 1 Clinical | Pascal Biosciences | Influenza A virus infections | Details | |
| adenovector based vaccine (Pascal Biosciences/University of British Columbia) | Phase 1 Clinical | Nevis Brands Inc | Influenza A virus infections | Details | |
| 90Y-2IT-BAD-Lym-1 | 90Y-2IT-BAD-Lym-1 | Phase 1 Clinical | National Cancer Institute | Lymphoma, Non-Hodgkin | Details |
| Bezetabart debotansine | STRO-001; SP7675; SP-7675; BN-301 | Phase 1 Clinical | Sutro Biopharma Inc | Hematologic Neoplasms; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Multiple Myeloma | Details |
| TROP-2-targeted anti-CD74 siRNA (Immunomedics) | Immunomedics Inc | Solid tumours | Details |